FDA Investigator Kimetha A King
Kimetha A King has inspections in 1 countries as of 12 May 2023. Kimetha A King has collaborated with a combined 895 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
44
Last Inspection Date:
12 May 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
A Williams,
Alan P Kurtzberg,
Amanda S Zorn,
Andrew M Kolenc,
Ashleigh P Barkans,
Ashleigh P Wodushek,
Azotearc,
Bryan J Love,
Chelsea N Sealey,
Christine I Shaw,
Daniel J Lahar,
Debra L Curtis,
Dustin M James,
Erika V Butler,
Felix J Marrero,
Frank L Cordova,
Genoula K Ryan,
Ginger M Sykes,
Grace E Mcnally,
Hanna L Potter,
Harperd,
Jamie L Dion,
Janet Pulver,
John Diehl,
Jonathan R Campos,
Justin H Erickson,
Kathleen S Tormey,
Keith C Littrell,
Kristen E Szenderski,
Lori A Carr,
Lori A Lahmann,
Manuel A Moreno,
Marc A Jackson, Jr,
Martina E Lagrange,
Matthew M Vernon,
Matthew R Dionne,
Michael J Kuchta,
Michael R Goga,
Michelle D Motsinger,
Nathan M Jornod,
Nicholas R Nance,
Patricia A Maestas,
Philip E Ake,
Ricki A Chase,
Shererk,
State Agency,
Steve P Yost,
Teena H Aiken,
Thai T Duong,
Theressa B Smith,
Tuan A Nguyen,
Vicky L Cruz,
Vivian Garcia,
Zachary L Miller,
Zachary L Stamm
Kimetha A King's Documents
Publish Date | Document Type | Title |
---|---|---|
February, 2010 | FDA 483 | Koko, LLC - Form 483, 2010-02-09 |
December, 2009 | FDA 483 | Encision Inc. - Form 483, 2009-12-11 |
November, 2007 | FDA 483 | VIBE Technologies - Form 483, 2007-11-16 |
March, 2009 | EIR | ARCA biopharma, Inc. - EIR, 2009-03-09 |
March, 2009 | FDA 483 Response | ARCA biopharma, Inc. - Form 483R, 2009-04-03 |
April, 2010 | FDA 483 | Septodont, Inc - Form 483, 2010-04-14 |
August, 2010 | FDA 483 | BioFire Diagnostics, LLC - Form 483, 2010-08-05 |
March, 2009 | FDA 483 | ARCA biopharma, Inc. - Form 483, 2009-03-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more